Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis

Steven MM, Van der Linden SM, Cats A (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Rheumatology 24(3):242–249 Brown MA (2009) Genetics and the pathogenesis of ankylosing spondylitis. Curr Opin Rheumatol 21(4):318–323 Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY (1998) Features of spondyloarthritis around the world. Rheum Dis Clin N Am 24(4):753–770 Reveille JD (2009) Recent studies on the genetic basis of ankylosing spondylitis. Curr Rheumatol Rep 11(5):340–348 Gunal EK, Sarvan FO, Kamali S, Gul A, Inanc M, Carin M, Konice M, Aral O, Ocal L (2008) Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Joint Bone Spine 75(3):299–302 Alaez C, Gazit E, Ibarrola B, Yaron M, Livneh A, Avishai O, Gorodezky C (2007) Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch Med Res 38(4):452–455 Nicknam MH, Mahmoudi M, Amirzargar AA, Hakemi MG, Khosravi F, Jamshidi AR, Amirkhani A, Ansaripour B, Pourpak Z, Moin M (2008) Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis. Iranian Journal of Allergy, Asthma and Immunology 7(1):19–24 Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31(4):325–330 Singleton AB, Hardy J, Traynor BJ, Houlden H (2010) Towards a complete resolution of the genetic architecture of disease. Trends Genet 26(10):438–442 Waddington CH (1942) Canalization of development and the inheritance of acquired characters. Nature 150(3811):563–565 Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome—biological and translational implications. Nat Rev Cancer 11(10):726–734 Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293(5532):1068–1070 Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D, Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55(20):4525–4530 Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1(7):686–692 Moll J, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32(4):354 Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291 Calin A, Garrett S, Whitelock H, Kennedy L, O’hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21(12):2281–2285 Jenkinson TR, Mallorie PA, Whitelock H, Kennedy LG, Garrett S, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21(9):1694–1698 Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3(6):1101–1108 Patterson K, Molloy L, Qu W, Clark S (2011) DNA methylation: bisulphite modification and analysis. Journal of visualized experiments: JoVE (56) Aslani S, Mahmoudi M, Karami J, Jamshidi AR, Malekshahi Z, Nicknam MH (2016) Epigenetic alterations underlying autoimmune diseases. Autoimmunity:1–15 Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13(7):484–492 Pimentel-Santos FM, Ligeiro D, Matos M, Mourão AF, Costa J, Santos H, Barcelos A, Godinho F, Pinto P, Cruz M (2011) Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther 13(2):R57 Lai N-S, Chou J-L, Chen GC, Liu S-Q, Lu M-C, Chan MW (2014) Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis. Mol Biol Rep 41(6):3773–3780 Bird AP, Wolffe AP (1999) Methylation-induced repression—belts, braces, and chromatin. Cell 99(5):451–454 Jones PA, Liang G (2009) Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 10(11):805–811 Lawson BR, Eleftheriadis T, Tardif V, Gonzalez-Quintial R, Baccala R, Kono DH, Theofilopoulos AN (2012) Transmethylation in immunity and autoimmunity. Clin Immunol 143(1):8–21 Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC (2013) Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clinical & Experimental Immunology 173(1):47–57 Huang J, Song G, Yin Z, Luo X, Ye Z (2014) Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis. Mod Rheumatol 24(2):331–334 Jiang Y, Wang L (2016) Role of histone deacetylase 3 in ankylosing spondylitis via negative feedback loop with microRNA-130a and enhancement of tumor necrosis factor-1α expression in peripheral blood mononuclear cells. Mol Med Rep 13(1):35–40 Huang C-H, Wei JC-C, Chang W-C, Chiou S-Y, Chou C-H, Lin Y-J, Hung P-H, Wong R-H (2014) Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration. J Rheumatol 41(6):1104–1111